Woodstock Corp Abb Vie Inc. Transaction History

Woodstock Corp

$1.03 Billion
Q3 2024

A detailed history of Woodstock Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Woodstock Corp holds 95,874 shares of ABBV stock, worth $17.3 Million. This represents 1.84% of its overall portfolio holdings.

Number of Shares

95,874

Previous 95,955 0.08%

Holding current value

$17.3 Million

Previous $16.5 Million 15.04%

% of portfolio

1.84%

Previous 1.69%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$163.84 - $199.33 $13,271 - $16,145	-81 Reduced 0.08%	95,874 $18.9 Million
Q2 2024 Jul 08, 2024	SELL	$154.79 - $180.76 $16,562 - $19,341	-107 Reduced 0.11%	95,955 $16.5 Million
Q1 2024 Apr 09, 2024	SELL	$159.82 - $182.1 $86,462 - $98,516	-541 Reduced 0.56%	96,062 $17.5 Million
Q4 2023 Jan 08, 2024	BUY	$137.6 - $154.97 $8,256 - $9,298	60 Added 0.06%	96,603 $15 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $45,687 - $52,890	-342 Reduced 0.35%	96,543 $14.4 Million
Q2 2023 Jul 07, 2023	SELL	$132.51 - $164.9 $3,577 - $4,452	-27 Reduced 0.03%	96,885 $13.1 Million
Q1 2023 Apr 06, 2023	SELL	$144.61 - $166.54 $76,209 - $87,766	-527 Reduced 0.54%	96,912 $15.4 Million
Q4 2022 Jan 10, 2023	BUY	$138.31 - $165.87 $243,978 - $292,594	1,764 Added 1.84%	97,439 $0
Q3 2022 Oct 11, 2022	SELL	$134.21 - $153.93 $1.27 Million - $1.46 Million	-9,476 Reduced 9.01%	95,675 $12.8 Million
Q2 2022 Jul 11, 2022	SELL	$137.62 - $174.96 $20,918 - $26,593	-152 Reduced 0.14%	105,151 $16.1 Million
Q1 2022 Apr 07, 2022	SELL	$131.98 - $163.75 $972,560 - $1.21 Million	-7,369 Reduced 6.54%	105,303 $17.1 Million
Q4 2021 Jan 07, 2022	BUY	$107.43 - $135.93 $44,476 - $56,275	414 Added 0.37%	112,672 $15.3 Million
Q3 2021 Oct 05, 2021	SELL	$106.4 - $120.78 $8,192 - $9,300	-77 Reduced 0.07%	112,258 $12.1 Million
Q2 2021 Jul 06, 2021	BUY	$105.21 - $117.21 $399,377 - $444,929	3,796 Added 3.5%	112,335 $12.7 Million
Q1 2021 Apr 05, 2021	BUY	$102.3 - $112.62 $124,294 - $136,833	1,215 Added 1.13%	108,539 $11.7 Million
Q4 2020 Jan 06, 2021	BUY	$80.49 - $108.67 $322,201 - $435,006	4,003 Added 3.87%	107,324 $11.5 Million
Q3 2020 Oct 02, 2020	BUY	$85.91 - $100.83 $165,892 - $194,702	1,931 Added 1.9%	103,321 $9.05 Million
Q2 2020 Jul 07, 2020	BUY	$73.37 - $98.18 $959,973 - $1.28 Million	13,084 Added 14.82%	101,390 $9.95 Million
Q1 2020 Apr 03, 2020	BUY	$64.5 - $97.79 $89,010 - $134,950	1,380 Added 1.59%	88,306 $6.73 Million
Q4 2019 Jan 13, 2020	SELL	$72.13 - $90.25 $13,704 - $17,147	-190 Reduced 0.22%	86,926 $7.7 Million
Q3 2019 Oct 02, 2019	BUY	$62.98 - $75.72 $2,645 - $3,180	42 Added 0.05%	87,116 $6.6 Million
Q2 2019 Jul 03, 2019	BUY	$65.7 - $83.98 $5,584 - $7,138	85 Added 0.1%	87,074 $6.33 Million
Q1 2019 Apr 05, 2019	SELL	$77.14 - $90.79 $65,337 - $76,899	-847 Reduced 0.96%	86,989 $7.01 Million
Q4 2018 Jan 08, 2019	SELL	$77.85 - $96.01 $151,029 - $186,259	-1,940 Reduced 2.16%	87,836 $8.1 Million
Q3 2018 Oct 03, 2018	SELL	$88.91 - $98.84 $49,789 - $55,350	-560 Reduced 0.62%	89,776 $8.49 Million
Q2 2018 Jul 23, 2018	SELL	$89.78 - $106.23 $111,776 - $132,256	-1,245 Reduced 1.36%	90,336 $8.37 Million
Q1 2018 Apr 19, 2018	SELL	$92.01 - $123.21 $264,988 - $354,844	-2,880 Reduced 3.05%	91,581 $8.67 Million
Q4 2017 Jan 24, 2018	BUY	$89.56 - $98.21 $112,218 - $123,057	1,253 Added 1.34%	94,461 $9.14 Million
Q3 2017 Oct 06, 2017	BUY	$69.85 - $89.22 $6.51 Million - $8.32 Million	93,208	93,208 $8.28 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodstock Corp, based on Form 13F filings with the SEC.

News

Stay updated on Woodstock Corp with notifications on news.

Account